Loading...
Menicon Co Ltd
MECNY•PNK
Healthcare
Medical - Instruments & Supplies
$88.63
$0.00(0.00%)
Menicon Co Ltd (MECNY) Financial Performance & Statements
Review Menicon Co Ltd’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
5.44%
↑ 5.44%
Operating Income Growth
-25.79%
↓ 25.79%
Net Income Growth
-38.48%
↓ 38.48%
Operating Cash Flow Growth
-6.93%
↓ 6.93%
Operating Margin
8.27%
↑ 8.27%
Gross Margin
53.57%
↑ 53.57%
Net Profit Margin
4.63%
↑ 4.63%
ROE
6.70%
↑ 6.70%
ROIC
6.25%
↑ 6.25%
Menicon Co Ltd (MECNY) Financial Statements
Explore quarterly and annual reports for Menicon Co Ltd stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $28.79B | $29.27B | $29.68B | $28.45B |
| Cost of Revenue | $13.62B | $13.89B | $14.31B | $13.37B |
| Gross Profit | $15.17B | $15.39B | $15.37B | $15.08B |
| Gross Profit Ratio | $0.53 | $0.53 | $0.52 | $0.53 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expenses | $13.75B | $13.11B | $12.73B | $12.46B |
| Total Costs & Expenses | $27.37B | $27.00B | $27.04B | $25.83B |
| Interest Income | $29.00M | $24.00M | $18.00M | $11.00M |
| Interest Expense | $146.00M | $151.00M | $144.00M | $130.00M |
| Depreciation & Amortization | $0.00 | $183.00M | $68.00M | -$14.00M |
| EBITDA | -$80.00M | $2.46B | $2.70B | $2.60B |
| EBITDA Ratio | -$0.003 | $0.08 | $0.09 | $0.09 |
| Operating Income | $1.42B | $2.28B | $2.64B | $2.62B |
| Operating Income Ratio | $0.05 | $0.08 | $0.09 | $0.09 |
| Other Income/Expenses (Net) | -$1.65B | $32.00M | -$76.00M | -$144.00M |
| Income Before Tax | -$226.00M | $2.31B | $2.56B | $2.47B |
| Income Before Tax Ratio | -$0.008 | $0.08 | $0.09 | $0.09 |
| Income Tax Expense | -$190.00M | $1.05B | $815.00M | $895.00M |
| Net Income | -$38.00M | $1.25B | $1.74B | $1.58B |
| Net Income Ratio | -$0.001 | $0.04 | $0.06 | $0.06 |
| EPS | -$0.03 | $1.03 | $1.43 | $1.30 |
| Diluted EPS | -$0.03 | $0.95 | $1.32 | $1.20 |
| Weighted Avg Shares Outstanding | $1.22B | $1.22B | $1.22B | $1.22B |
| Weighted Avg Shares Outstanding (Diluted) | $1.32B | $1.32B | $1.32B | $1.32B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan